Stephen C. Mahoney
Hogan Lovells
Articles
Results 1 to 1 of 1
Current trends in FDA’s pharmaceutical good manufacturing practice (GMP) warning letters
USA - April 22 2009 In the past twelve months, the U.S. Food and Drug Administration (FDA) has issued more than 25 Warning Letters to manufacturers of finished pharmaceuticals and active pharmaceutical ingredients (APIs) for violations of the current good manufacturing practice (GMP) regulations.
